Hypertension Diagnostics, Inc.
HDII
Rank in Stocks
#34166
Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops,... Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops, manufactures, and commercializes its own innovative, non-invasive medical technologies. These devices are engineered to identify minute changes in the flexibility of arteries, serving both domestic and international markets. Central to their offerings is the CVProfilor, a system designed for non-invasive assessment of both large and small artery elasticity. The elasticity of small arteries is especially critical, serving as the earliest and most sensitive indicator of cardiovascular disease. The product suite includes the CVProfilor DO-2020, which delivers essential arterial elasticity indices, aiding in the diagnosis of underlying vascular conditions. Its counterpart, the CVProfilor MD-3000, offers precise and specific insights into the presence of blood vessel disease. For scientific study, the HD/PulseWave CR-2000 is a specialized cardiovascular profiling system, equipping scientists and investigators with a non-intrusive method to evaluate arterial elasticity across diverse human research domains. These devices operate by capturing 30 seconds of blood pressure waveform data, subsequently analyzing the digitized patterns to generate a comprehensive CVProfile report. This report details crucial metrics including blood pressure, heart rate, pulse pressure, body surface area, body mass index, and indices for both C1 (large) and C2 (small) artery elasticity. HDII caters to a broad spectrum of clients, including general practitioners, cardiologists, various healthcare practitioners, skilled medical staff, academic and government research scientists, cardiovascular specialists, and pharmaceutical companies. In the U.S., sales are facilitated by a dedicated network of representatives. Established in 1988, Hypertension Diagnostics, Inc. maintains its headquarters in Richmond Hill, Canada.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$28.48K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hypertension Diagnostics, Inc. (HDII)
Category
Financial Services
EPS for Hypertension Diagnostics, Inc. (HDII)
EPS as of March 2023 TTM: $0.00
According to Hypertension Diagnostics, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2021 the company had an EPS of 0.00, equal to its 2020 EPS of 0.00.
EPS history for Hypertension Diagnostics, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 300.00% |
| 2021 | 0.00 | 300.00% |
| 2020 | 0.00 | -100.41% |
| 2019 | $0.02 | -2,777.78% |
| 2018 | 0.00 | -76.92% |
| 2017 | 0.00 | -99.97% |
| 2016 | $-11.87 | 43,862.96% |
| 2012 | $-0.03 | -370.00% |
| 2011 | $0.01 | -150.00% |
| 2010 | $-0.02 | 227.87% |
| 2009 | $-0.01 | -69.50% |
| 2008 | $-0.02 | 100.00% |
| 2007 | $-0.01 | -75.00% |
| 2006 | $-0.04 | -20.00% |
| 2005 | $-0.05 | -37.50% |
| 2004 | $-0.08 | -82.22% |
| 2003 | $-0.45 | -57.94% |
| 2002 | $-1.07 | 154.76% |
| 2001 | $-0.42 | -35.38% |
| 2000 | $-0.65 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $0.00 | -140.00% |
US
|
|
| $0.38 | -15,300.00% |
US
|
|
| $0.00 | 0.00% |
CN
|
|
| $0.09 | -3,500.00% |
US
|
|
| $-3.24 | 129,500.00% |
US
|
Questions about Hypertension Diagnostics, Inc.'s earnings per share (EPS)
What is Hypertension Diagnostics, Inc.'s earnings per share (EPS)?
Hypertension Diagnostics, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Mar 2023.
What was Hypertension Diagnostics, Inc.'s earnings per share (EPS) in 2021?
In 2021, Hypertension Diagnostics, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2020.
How has Hypertension Diagnostics, Inc.'s earnings per share (EPS) changed since 2016?
From 2016 to 2021, Hypertension Diagnostics, Inc.'s earnings per share (EPS) was highest in 2019 ($0.02) and lowest in 2016 ($-11.87).
How does Hypertension Diagnostics, Inc.'s earnings per share (EPS) compare with similar companies?
Hypertension Diagnostics, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Worldwide Webb Acquisition Corp., with $0.38.